Full Press Release Details
Biogen Idec and Eisai Announce Manufacturing Alliance at Research Triangle Park Facilities.
BIIB
Biogen Idec and Eisai Announce Manufacturing Alliance at Research Triangle Park Facilities
Key Takeaway: Biogen Idec and Eisai Announce Manufacturing Alliance at Research Triangle Park Facilities
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis